ScoreWhy is Arecor Therapeutics Plc ?
1
Poor Management Efficiency with a low ROE of 0%
- The company has reported losses. Due to this company has reported negative ROE
2
The company is Net-Debt Free
- Poor long term growth as Net Sales has grown by an annual rate of 0.40% and Operating profit at 1.37% over the last 5 years
- The company is Net-Debt Free
- The company has reported losses. Due to this company has reported negative ROE
3
Poor long term growth as Net Sales has grown by an annual rate of 0.40% and Operating profit at 1.37% over the last 5 years
4
Flat results in Jun 24
- ROCE(HY) Lowest at -94.76%
- CASH AND EQV(HY) Lowest at GBP 2.54 MM
5
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -2.54%, its profits have fallen by -2470%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Arecor Therapeutics Plc for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Arecor Therapeutics Plc
-2.54%
-1.56
35.11%
FTSE 100
19.78%
1.58
11.75%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
0.40%
EBIT Growth (5y)
1.37%
EBIT to Interest (avg)
-4.37
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.59
Sales to Capital Employed (avg)
0.00
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
3.66
EV to EBIT
-5.79
EV to EBITDA
-6.11
EV to Capital Employed
17.56
EV to Sales
17.56
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-303.28%
ROE (Latest)
-369.90%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bearish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend
Not enough Data to analyse Financial Trend
Not enough Data to analyse Financial Trend
Here's what is working for Arecor Therapeutics Plc
Net Profit
Higher at GBP -4.64 MM
than preceding 12 month period ended Jun 2024MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (GBP MM)
Here's what is not working for Arecor Therapeutics Plc
Cash and Eqv
Lowest at GBP 2.54 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
